Back to search
FDAFDA · Food and drugs·Recall number D-0528-2023

Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular or Subcutaneous Use Only, Rx Only, Sterile, Manufactured by: Intas Pharmaceuticals Limited Pharmaz Ahnedabad 382 213, INDIA, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-533-08.

Published April 12, 2023 · Recall initiated: March 29, 2023

Summary

FDA records drug Class III recall D-0528-2023, published April 12, 2023 and initiated March 29, 2023. Recalling firm: Accord Healthcare, Inc.; Status: Terminated; Reported quantity: 4574 cartons; Lot: Lot #: R2200394 Exp. 03/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sub-potent drug: assay test result below specifications at 9-month timepoint.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Accord Healthcare, Inc.
Distributor
Nationwide in the USA.
Lot
Lot #: R2200394 Exp. 03/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular or Subcutaneous Use Only, Rx Only, Sterile, Manufactured by: Intas Pharmaceuticals Limited Pharmaz Ahnedabad 382 213, INDIA, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-533-08. recalled?

Yes. FDA published recall D-0528-2023 on April 12, 2023. Reported hazard: Sub-potent drug: assay test result below specifications at 9-month timepoint.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail